Carbidopa And Levodopa Capsule, Extended Release
Product Images NDC 70710-2139

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 70710-2139). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (10c40374 C287 4608 Bd08 5bab623bbe1d 01)

FDA Label Image

Image (10c40374 C287 4608 Bd08 5bab623bbe1d 02)

FDA Label Image

Carbidopa And Levodopa Extended-release Capsules, 23.75 mg/95 mg (10c40374 C287 4608 Bd08 5bab623bbe1d 03)

FDA Label Image

Carbidopa And Levodopa Extended-release Capsules, 36.25 mg/145 mg (10c40374 C287 4608 Bd08 5bab623bbe1d 04)

This text appears to be a set of instructions and information related to a medication product. The product seems to be capsules containing Carbidopa and Levodopa, with a dosage of 36.25 mg/145 mg per capsule. The recommended dosage and storage instructions are provided, as well as details on the manufacturer and distributor. The text emphasizes the importance of keeping the medication out of reach of children.*

FDA Label Image

Carbidopa And Levodopa Extended-release Capsules, 48.75 mg/195 mg (10c40374 C287 4608 Bd08 5bab623bbe1d 05)

This text provides information about an extended-release capsule containing Carbidopa and Levodopa, manufactured by Bora Pharmaceutical Laboratories Inc. and distributed by Zydus Pharmaceuticals (USA) Inc. The recommended dosage details are found in the package insert. It is advised to store the capsules in a tightly closed container, protected from light and moisture, at a temperature range specified in Celsius and Fahrenheit. The medication should be dispensed in a light-resistant container as defined in the USP. Additionally, it emphasizes keeping this and all drugs out of the reach of children.*

FDA Label Image

Carbidopa And Levodopa Extended-release Capsules, 61.25 mg/245 mg (10c40374 C287 4608 Bd08 5bab623bbe1d 06)

This text provides information about a medication called Carbidopa and Levodopa in extended-release capsules. It includes details such as recommended dosage, storage instructions, and the manufacturer's information. The medication is presented in 61.25 mg/245 mg capsule form and is designed to be dispensed in a light-resistant container.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.